Maynard Um
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $310 at Needham
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised at Piper Sandler as 'Zepzelca Strength Continues'
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $307 at BofA Securities
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $258 at RBC Capital
-
-
-
-
-
-
-
Barclays Starts Jazz Pharmaceuticals (JAZZ) at Overweight (earlier)
-
-
-
-
-
-
-
4Q25/2026 Biotech Earnings Preview: RBC
-
-
-
-
-
-
-
UBS Downgrades Jazz Pharmaceuticals (JAZZ) to Neutral
-
455,516 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

